Investment Firm
Overview
Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.
Jan 05, 2023
Series D
Highlights
N/A
Location
Social
N/A
Investor Lead
N/A
Participant Investors
3
Investor Name |
---|
Biotechnology Value Fund |
Nolan Capital |
BioAdvance |
Palvella Therapeutics raised $37700000 on 2023-01-05 in Series D
Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.
Company Funding History
6
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
May 28, 2020 | Series C - Palvella Therapeutics | 9 | - | 45.0M |
Dec 30, 2022 | Venture Round - Palvella Therapeutics | - | 9.7M | |
Jan 05, 2023 | Series D - Palvella Therapeutics | 7 | - | 37.7M |
Aug 14, 2017 | Venture Round - Palvella Therapeutics | 2 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.